Global Blinatumomab Market Professional Survey Report 2019
Table of Contents
Executive Summary
1 Industry Overview of Blinatumomab
- 1.1 Definition of Blinatumomab
- 1.2 Blinatumomab Segment by Type
- 1.2.1 Global Blinatumomab Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Prefilled
- 1.2.3 Non-prefilled
- 1.3 Blinatumomab Segment by Applications
- 1.3.1 Global Blinatumomab Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospital
- 1.3.3 Pharmacy
- 1.4 Global Blinatumomab Overall Market
- 1.4.1 Global Blinatumomab Revenue (2014-2025)
- 1.4.2 Global Blinatumomab Production (2014-2025)
- 1.4.3 North America Blinatumomab Status and Prospect (2014-2025)
- 1.4.4 Europe Blinatumomab Status and Prospect (2014-2025)
- 1.4.5 China Blinatumomab Status and Prospect (2014-2025)
- 1.4.6 Japan Blinatumomab Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Blinatumomab Status and Prospect (2014-2025)
- 1.4.8 India Blinatumomab Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Blinatumomab
- 2.3 Manufacturing Process Analysis of Blinatumomab
- 2.4 Industry Chain Structure of Blinatumomab
3 Development and Manufacturing Plants Analysis of Blinatumomab
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Blinatumomab Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Blinatumomab
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Blinatumomab Production and Capacity Analysis
- 4.2 Blinatumomab Revenue Analysis
- 4.3 Blinatumomab Price Analysis
- 4.4 Market Concentration Degree
5 Blinatumomab Regional Market Analysis
- 5.1 Blinatumomab Production by Regions
- 5.1.1 Global Blinatumomab Production by Regions
- 5.1.2 Global Blinatumomab Revenue by Regions
- 5.2 Blinatumomab Consumption by Regions
- 5.3 North America Blinatumomab Market Analysis
- 5.3.1 North America Blinatumomab Production
- 5.3.2 North America Blinatumomab Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Blinatumomab Import and Export
- 5.4 Europe Blinatumomab Market Analysis
- 5.4.1 Europe Blinatumomab Production
- 5.4.2 Europe Blinatumomab Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Blinatumomab Import and Export
- 5.5 China Blinatumomab Market Analysis
- 5.5.1 China Blinatumomab Production
- 5.5.2 China Blinatumomab Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Blinatumomab Import and Export
- 5.6 Japan Blinatumomab Market Analysis
- 5.6.1 Japan Blinatumomab Production
- 5.6.2 Japan Blinatumomab Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Blinatumomab Import and Export
- 5.7 Southeast Asia Blinatumomab Market Analysis
- 5.7.1 Southeast Asia Blinatumomab Production
- 5.7.2 Southeast Asia Blinatumomab Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Blinatumomab Import and Export
- 5.8 India Blinatumomab Market Analysis
- 5.8.1 India Blinatumomab Production
- 5.8.2 India Blinatumomab Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Blinatumomab Import and Export
6 Blinatumomab Segment Market Analysis (by Type)
- 6.1 Global Blinatumomab Production by Type
- 6.2 Global Blinatumomab Revenue by Type
- 6.3 Blinatumomab Price by Type
7 Blinatumomab Segment Market Analysis (by Application)
- 7.1 Global Blinatumomab Consumption by Application
- 7.2 Global Blinatumomab Consumption Market Share by Application (2014-2019)
8 Blinatumomab Major Manufacturers Analysis
- 8.1 Amgen
- 8.1.1 Amgen Blinatumomab Production Sites and Area Served
- 8.1.2 Amgen Product Introduction, Application and Specification
- 8.1.3 Amgen Blinatumomab Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
9 Development Trend of Analysis of Blinatumomab Market
- 9.1 Global Blinatumomab Market Trend Analysis
- 9.1.1 Global Blinatumomab Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Blinatumomab Regional Market Trend
- 9.2.1 North America Blinatumomab Forecast 2019-2025
- 9.2.2 Europe Blinatumomab Forecast 2019-2025
- 9.2.3 China Blinatumomab Forecast 2019-2025
- 9.2.4 Japan Blinatumomab Forecast 2019-2025
- 9.2.5 Southeast Asia Blinatumomab Forecast 2019-2025
- 9.2.6 India Blinatumomab Forecast 2019-2025
- 9.3 Blinatumomab Market Trend (Product Type)
- 9.4 Blinatumomab Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Blinatumomab Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Blinatumomab (trade name Blincyto) is a biopharmaceutical drug used as a second-line treatment for Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia.
The global Blinatumomab market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Blinatumomab volume and value at global level, regional level and company level. From a global perspective, this report represents overall Blinatumomab market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Blinatumomab in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Blinatumomab manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Amgen
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Prefilled
Non-prefilled
Segment by Application
Hospital
Pharmacy